Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
Researchers from University of Gottingen describe findings in clinical trial research
July 15th, 2007
New investigation results, "Dietary daidzein and puerarin do not affect pituitary LH expression but exert uterotropic effects in ovariectomized rats," are detailed in a study published in Maturitas. In this recent report, researchers in Germany conducted a study "To investigate the potency of LH suppression, as an indirect measure of alleviation of postmenopausal vasomotor symptoms, as well as the uterotropic effects of two isoflavones: daidzein and puerarin in an ovariectomized (ovx) rat model and compare them with the effects of 17beta-estradiol benzoate (E2B). Eighty female Sprague-Dawley rats were ovx and divided into six different treatment groups and one control group (11-12...
Source: Aging & Elder Health Week (2007-07-15)
|
|
Advertisement |
|
|
|
